January 19, 2019

Celltrion surpasses Hyundai Motor in market value

PUBLISHED : January 08, 2018 - 16:56

UPDATED : January 08, 2018 - 16:56

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • 트위터
  • sms

[THE INVESTOR] Drug maker Celltrion’s stock has made significant gains in recent days, surpassing Hyundai Motor in terms of market value, data showed Jan. 8.

Celltrion shares jumped 55.12 percent over the past seven trading sessions to 302,500 won (US$283.29), pushing the company’s capitalization to a record 37.1 trillion won. Hyundai’s market capitalization stood at 33.2 trillion won.

Celltrion’s stock has already exceeded target prices by brokerages.

The surge in its stock price came as the company is scheduled to move to the benchmark KOSPI market next month from the junior KOSDAQ market. 

Hong Ka-hye, an analyst at Daishin Securities, said foreign investors have snapped up Celltrion shares in recent trading sessions.

Analysts expected shares of Celltrion to rise further as the company is likely to win government approval for more new products going forward.

By Alex Lee and newswires (

  • 페이스북
  • 트위터
  • sms
Herald Corporation|CEO : Kwon Chung Won
Chief Privacy Officer & Juvenile Protection Manager : Yang Sung-jin
Company Registration No. 104-81-06004
Mail-Order Business Registration 2016 - Seoul Yongsan - 00590
Huam-ro 4-gil 10, Yongsan-gu, Seoul, Korea
T : +82-2-727-0114|Business info
Gov’t registration No. 아 04099